Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06403657
Other study ID # DETECT-B protocol
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 2024
Est. completion date July 2025

Study information

Verified date May 2024
Source Vietnam Viral Hepatitis Alliance
Contact Thanh Kim, MD
Email thanhkv@pnt.edu.vn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overarching goal of this implementation study is to determine if an enhanced model of hepatitis B testing and linkage to care could be integrated into a public healthcare facility. To answer this question, the investigators will 1. evaluate the effectiveness of the implementation program (overall impact or individual components) in increasing the use of testing services and linkage to hepatitis B care and treatment, 2. evaluate implementation fidelity, sustainability, and integration of the implementation study and 3. analyze the costs and cost-effectiveness of the implementation study.


Description:

Chronic hepatitis B (CHB) poses a significant public health challenge, particularly in low-income countries like Viet Nam. Despite the development of various diagnostic and treatment tools for hepatitis B, the delivery of these services remains suboptimal. In response, the investigators seek to assess the feasibility of integrating an enhanced model for hepatitis B testing and linkage to care within a public healthcare facility. The study aims to address this issue through several key objectives: 1. Effectiveness Evaluation: The investigators will evaluate the impact of the implementation program on increasing the utilization of testing services and linkage to hepatitis B care and treatment. This includes assessing the overall impact as well as the effectiveness of individual program components. 2. Implementation Fidelity and Sustainability: The investigators aim to evaluate the fidelity of implementation, examine how well the program is executed, and assess its potential for sustainability and integration into routine healthcare practices. 3. Cost and Cost-Effectiveness Analysis: The investigators will analyze the costs associated with the implementation of the program and its cost-effectiveness in improving hepatitis B testing and linkage to care. The implementation study is based at Le Van Thinh Hospital in Thu Duc City, Ho Chi Minh City. This study is guided by the EPIS (Explore - Prepare - Implement - Sustain) conceptual framework, which informs our research development, implementation, and evaluation strategies. A mixed-method quasi-experimental type II hybrid effectiveness-implementation design will be employed. This involves implementing various strategies to enhance hepatitis B testing sequentially over a 12-month period. Strategies include medical education for primary care providers, electronic medical record-based reminders for testing, and point-of-care testing for CHB. Effectiveness will be assessed using interrupted time series analysis with electronic medical record data. Sustainability will be gauged through interviews or focus group discussions with healthcare providers and patients. Cost evaluation will utilize activity-based costing and cost-effectiveness analysis. The study aims to generate evidence on the effectiveness and implementation of an enhanced model for hepatitis B screening and care linkage within a primary care setting at a public hospital. The findings are anticipated to be applicable to similar settings in Viet Nam and other lower-middle-income countries globally.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date July 2025
Est. primary completion date July 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion criteria for patients - Patients who visit the outpatient clinics at Le Van Thinh Hospital during the study period. - Consent to use point-of-care HBsAg testing after being fully informed by the health care providers (this only applies during the last 4-month period where POC-HBsAg testing is introduced). Exclusion criteria for patients: None Inclusion criteria for healthcare providers and leaders - Healthcare providers who work in the outpatient department and are involved in the enhanced model during the 12-month implementation period. - Leaders who are involved in the enhanced model or make decisions or are authorized to to so relating to the enhanced model. - Consent to join the in-depth interview or focus group after being fully informed by the study investigators. Exclusion criteria for healthcare providers and leaders: None

Study Design


Related Conditions & MeSH terms


Intervention

Other:
An enhanced model of hepatitis B testing and linkage to care
Implementing CME sessions (<50 attendees) at Le Van Thinh Hospital will focus on preventive strategies for hepatitis B (HBV). We'll collaborate with IT to integrate a Best Practice Advisory (BPA) system into the hospital's electronic records for hepatitis B testing reminders. The system prompts healthcare workers when a patient lacks HBV screening notes, ensuring timely education and testing. Also, we'll introduce Point-of-Care (POC) HBsAg testing using SD Bioline HBsAg WB® for efficient screening and counseling, with follow-up to ensure care linkage within two weeks.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Vietnam Viral Hepatitis Alliance Le Van Thinh Hospital, Viet Nam, University of Medicine and Pharmacy at Ho Chi Minh City

Outcome

Type Measure Description Time frame Safety issue
Primary Change in number or proportion HBsAg testing at primary care clinics between pre- and implementation periods, extracted from electronic health records at Le Van Thinh hospital. The primary care clinics include general internal medicine clinics and family medicine clinics, located in the outpatient department. Up to 2 years (start one year before the implementation of the enhanced model and end one year after).
Primary Sustainability of the implementation of the enhanced model, as assessed by EPIS-based semi-structured/structured questionnaires. This is a qualitative outcome. The information will be collected through focus group discussions or in-depth interviews on healthcare staff. The EPIS (Exploration-Preparation-Implementation-Sustainment) is a conceptual framework used to guide the questionnaire and the discussions/interviews At Month 12 of the implementation period
Primary Activity-based costs The scope of the costing was limited to program implementation costs. At Month 12 of the implementation period
Secondary Change in linkage to hepatitis B care between pre- and implementation periods, extracted from electronic health records at Le Van Thinh hospital. Up to 2 years (start one year before the implementation of the enhanced model and end one year after).
See also
  Status Clinical Trial Phase
Recruiting NCT03854630 - Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection Phase 4
Recruiting NCT03985085 - Sexual and Reproductive Health (Including PrEP and HBV) for Female Sex Workers in Côte d'Ivoire N/A
Completed NCT01199601 - Blood-borne Infection Screening in an Afghan Antenatal Population N/A
Terminated NCT03032536 - Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers Phase 1
Not yet recruiting NCT04690972 - "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
Active, not recruiting NCT01953458 - Therapeutic Option for Hepatitis B and C: a French Cohort
Available NCT05683548 - Replicor Compassionate Access Program